ISPOR - PCR223 Considerations for the Development of Treatment Efficacy/Benefit Attributes and Levels in Patient Preference Studies

Full Text

PCR223 Considerations for the Development of Treatment Efficacy/Benefit Attributes and Levels in Patient Preference Studies

Abstract

Authors

B Mason S Tatlock A Gater

Back to Volume 27, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now